FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
NeuroOne Announces $3.5 Million Accelerated Milestone Payment from Zimmer Biomet for Evo® sEEG Electrode
NeuroOne notes the amendment provides Zimmer Biomet with 350,000 warrants with exercise price of $3.00 per share.
Partnership for Economic Innovation Secures Funding for Wearable Technology Research
Partnership for Economic Innovation notes the applied research model accelerates product development and commercialization by combining private and public sector.
Successful Completion of Series A: EUR 10 Million Investment for Medtech Startup PreciPoint
PreciPoint will launch the iO:M8 ROSE solution to customers in 2022, a globally unique solution for the digitization of intraoperative assessments during cancer surgeries.
Ceros Financial Services Arranges $15 Million Financing For GT Metabolic Solutions
Ceros Financial Services will apply the raise to complete initial clinical trials for its incisionless Duodenal Ilial Bypass anastomosis for bariatric and metabolic surgery.
Retia Medical Raises $15 Million Series B
Financing round was led by Fresenius Medical Care Ventures with participation from a second strategic investor, Red Cedar Ventures, and existing investor, the Pritzker-Vlock Family Office notes Retia Medical.
Vascular Dynamics Completes $20 Million Equity Financing to Support Further Clinical Evaluations of MobiusHD Device
The Vascular Dynamics MobiusHD device is designed to provide interventionalists with a minimally-invasive transcatheter approach to help treat patients suffering from continued heart failure problems despite pharmaceutical therapy.
Calyxo Raises $32.7 Million in Series C Financing
Calyxo notes the investment round will fund further product development and expansion of their Team.
PhysioMedics Poised for Growth Through Capital Fundraise Following CEO Appointment
Edinburgh-based PhysioMedics secured equity and grant funding totalling £1.5m from Archangels, Scottish Enterprise and Innovate UK.
Advanced NanoTherapies Announces Closing of Oversubscribed $7.2 Million Series A Financing
Funds will be used to complete the first-in-human clinical study in Australia of the SirPlux Duo drug-coated balloon in de-novo coronary artery disease lesions notes Advanced NanoTherapies.
Medical Device News Magazine
